Refractory Candida orthopsilosis endocarditis in a hemodialysis patient: The role of species-level identification and surgical source control
Related Experiment Video
Updated: Jun 14, 2026

A Catheter-Related Candida albicans Infection Model in Mouse
Published on: March 22, 2024
Maria Eduarda Pierre1, Alessandro Pascon Filho2, José Alberto Kfouri da Silva Trazzi1
1Barretos School of Health Sciences, Dr Paulo Prata - FACISB, Barretos, São Paulo, Brazil.
Purpose:
Candida orthopsilosis endocarditis is rare and underdiagnosed due to the inability of conventional biochemical platforms to achieve species-level identification within the Candida parapsilosis complex.
Methods:
We report a 60-year-old hemodialysis-dependent woman with diabetes mellitus and chronic kidney disease who developed catheter-related fungemia progressing to infective endocarditis.
Results:
C. orthopsilosis was identified by MALDI-TOF mass spectrometry. Broth microdilution per BrCAST/EUCAST demonstrated susceptibility to amphotericin B, fluconazole, and anidulafungin. Transesophageal echocardiography (TEE) revealed a mobile tricuspid valve vegetation fulfilling modified Duke Criteria for definite infective endocarditis. Despite antifungal therapy, blood cultures remained positive and septic pulmonary embolism developed. Surgical valve replacement achieved microbiological clearance within 24 hours; C. orthopsilosis was confirmed in excised tissue. Fluconazole step-down completed a six-week course.
Conclusion:
MALDI-TOF-guided species identification, susceptibility-directed echinocandin therapy, and timely surgical source control constitute an effective management framework for Candida endocarditis, achieving complete microbiological clearance despite severe systemic complications.
Related Concept Videos
Endocarditis III: Medical Management
Cryptococcal Meningitis
Endocarditis I: Introduction
Endocarditis IV: Nursing Management
Candidiasis
